Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PCVX
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Tuesday for Vaxcyte, Inc. stock after losing 1.14%
(Updated on Jul 02, 2024)

Buy or Hold candidate since May 30, 2024 Gain 8.33% PDF

The Vaxcyte, Inc. stock price fell by -1.14% on the last day (Tuesday, 2nd Jul 2024) from $76.94 to $76.06. During the last trading day the stock fluctuated 2.51% from a day low at $75.27 to a day high of $77.16. The price has risen in 7 of the last 10 days and is up by 5.82% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -435 thousand shares and in total, 495 thousand shares were bought and sold for approximately $37.64 million.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 25.08% during the next 3 months and, with a 90% probability hold a price between $89.57 and $99.49 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PCVX Signals & Forecast

The Vaxcyte, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $76.09. On a fall, the stock will find some support from the long-term average at approximately $72.59. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, June 27, 2024, and so far it has fallen -3.44%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Vaxcyte, Inc. stock

Vaxcyte, Inc. finds support from accumulated volume at $75.78 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.89 between high and low, or 2.51%. For the last week, the stock has had daily average volatility of 4.61%.

Our recommended stop-loss: $73.00 (-4.03%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 23 days ago.)

Trading Expectations (PCVX) For The Upcoming Trading Day Of Wednesday 3rd

For the upcoming trading day on Wednesday, 3rd we expect Vaxcyte, Inc. to open at $76.16, and during the day (based on 14 day Average True Range), to move between $73.38 and $78.74, which gives a possible trading interval of +/-$2.68 (+/-3.52%) up or down from last closing price. If Vaxcyte, Inc. takes out the full calculated possible swing range there will be an estimated 7.04% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $75.78 (0.37%) than the resistance at $76.94 (1.16%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Vaxcyte, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Vaxcyte, Inc. stock to perform well in the short-term.

Current score: 3.031 Buy Candidate Unchanged

Predicted Opening Price for Vaxcyte, Inc. of Wednesday, July 3, 2024

Fair opening price July 3, 2024 Current price
$76.16 ( 0.136%) $76.06

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PCVX

Fibonacci Support & Resistance Levels

Level Price
R3 78.05 2.62%
R2 77.33 1.67%
R1 76.89 1.09%
Price 76.06
S1 75.44 -0.81%
S2 75.00 -1.40%
S3 74.27 -2.35%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 78.77 3.56%
R1 76.94 1.16%
Price 76.06
S1 75.78 -0.368%
S2 75.51 -0.723%
S3 60.06 -21.04%

FAQ

What is the symbol for Vaxcyte, Inc. Stock and on which exchange is it traded?
The symbol for Vaxcyte, Inc. is PCVX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Vaxcyte, Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Vaxcyte, Inc. stock to perform well in the short-term.

How to buy Vaxcyte, Inc. Stock?
Vaxcyte, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Vaxcyte, Inc. Stock.

What's the current price of Vaxcyte, Inc. Stock?
As of the end of day on the Jul 02, 2024, the price of an Vaxcyte, Inc. (PCVX) share was $76.06.

What is the 52-week high and low for Vaxcyte, Inc. Stock?
The 52-week high for Vaxcyte, Inc. Stock is $82.04 and the 52-week low is $44.20.

What is the market capitalization of Vaxcyte, Inc. Stock?
As of the Jul 02, 2024, the market capitalization of Vaxcyte, Inc. is 8.371B.

When is the next earnings date for Vaxcyte, Inc.?
The upcoming earnings date for Vaxcyte, Inc. is Aug 13, 2024.
Click to get the best stock tips daily for free!

About Vaxcyte, Inc.

Vaxcyte. Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against emerging strains and address antibiotic resistance; VAX-A1, a co... PCVX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT